Ticlopidine Aspirin Stroke Study

Completed

Phase N/A Results

Summary of Purpose

To compare the effects of ticlopidine hydrochloride with those of aspirin on the risk of recurrent stroke or death.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 October 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Syntex Research, Palo Alto, CA

Trial Design

Randomized, stratified, double-blind trial of 3069 patients at 56 centers in the U.S. and Canada. Patients were stratified at each center by history of ischemic cardiovascular disease, the occurrence of a moderate or major stroke more than three months before entry, and sex.

Contacts

Not available